These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 18469354)

  • 41. Overexpression of KIAA0101 predicts poor prognosis in primary lung cancer patients.
    Kato T; Daigo Y; Aragaki M; Ishikawa K; Sato M; Kaji M
    Lung Cancer; 2012 Jan; 75(1):110-8. PubMed ID: 21689861
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical relevance of galectin-1 expression in non-small cell lung cancer patients.
    Carlini MJ; Roitman P; Nuñez M; Pallotta MG; Boggio G; Smith D; Salatino M; Joffé ED; Rabinovich GA; Puricelli LI
    Lung Cancer; 2014 Apr; 84(1):73-8. PubMed ID: 24560493
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Keratin 34betaE12/keratin7 expression is a prognostic factor of cancer-specific and overall survival in patients with early stage non-small cell lung cancer.
    Pøhl M; Olsen KE; Holst R; Donnem T; Busund LT; Bremnes RM; Al-Saad S; Andersen S; Richardsen E; Ditzel HJ; Hansen O
    Acta Oncol; 2016; 55(2):167-77. PubMed ID: 26057535
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Relationship between NOB1 expression and prognosis of resected non-small cell lung cancer.
    Liu K; Chen HL; Gu MM; You QS
    Int J Biol Markers; 2015 Feb; 30(1):e43-8. PubMed ID: 25450647
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of TAZ expression in resected non-small cell lung cancer.
    Xie M; Zhang L; He CS; Hou JH; Lin SX; Hu ZH; Xu F; Zhao HY
    J Thorac Oncol; 2012 May; 7(5):799-807. PubMed ID: 22481233
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer.
    Le H; Zeng F; Xu L; Liu X; Huang Y
    Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Regulation of p27 by S-phase kinase-associated protein 2 is associated with aggressiveness in non-small-cell lung cancer.
    Osoegawa A; Yoshino I; Tanaka S; Sugio K; Kameyama T; Yamaguchi M; Maehara Y
    J Clin Oncol; 2004 Oct; 22(20):4165-73. PubMed ID: 15483027
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1.
    Zheng J; Xu T; Chen F; Zhang Y
    Pathol Oncol Res; 2019 Jul; 25(3):1181-1190. PubMed ID: 30637589
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Bioinformatics analysis and experimental validation of TTK as a biomarker for prognosis in non-small cell lung cancer.
    Chen J; Wu R; Xuan Y; Jiang M; Zeng Y
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 32969465
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High expression of Cullin1 indicates poor prognosis for NSCLC patients.
    Xu M; Yang X; Zhao J; Zhang J; Zhang S; Huang H; Liu Y; Liu J
    Pathol Res Pract; 2014 Jul; 210(7):397-401. PubMed ID: 24767980
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance.
    Kikuchi J; Kinoshita I; Shimizu Y; Kikuchi E; Konishi J; Oizumi S; Kaga K; Matsuno Y; Nishimura M; Dosaka-Akita H
    Cancer; 2010 Jun; 116(12):3015-24. PubMed ID: 20564407
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CHCHD2 is a potential prognostic factor for NSCLC and is associated with HIF-1a expression.
    Yin X; Xia J; Sun Y; Zhang Z
    BMC Pulm Med; 2020 Feb; 20(1):40. PubMed ID: 32054470
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Significance of DEK overexpression for the prognostic evaluation of non-small cell lung carcinoma.
    Liu X; Qi D; Qi J; Mao Z; Li X; Zhang J; Li J; Gao W
    Oncol Rep; 2016 Jan; 35(1):155-62. PubMed ID: 26530274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non-small cell lung carcinoma.
    Qiu Y; Morii E; Tomita Y; Zhang B; Matsumura A; Kitaichi M; Okumura M; Aozasa K
    Cancer Sci; 2009 Jul; 100(7):1198-209. PubMed ID: 19356220
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Co-downregulation of PTEN, KAI-1, and nm23-H1 tumor/metastasis suppressor proteins in non-small cell lung cancer.
    Goncharuk VN; del-Rosario A; Kren L; Anwar S; Sheehan CE; Carlson JA; Ross JS
    Ann Diagn Pathol; 2004 Feb; 8(1):6-16. PubMed ID: 15129904
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein expression of close homologue of L1 (CHL1) is a marker for overall survival in non-small cell lung cancer (NSCLC).
    Hötzel J; Melling N; Müller J; Polonski A; Wolters-Eisfeld G; Izbicki JR; Karstens KF; Tachezy M
    J Cancer Res Clin Oncol; 2019 Sep; 145(9):2285-2292. PubMed ID: 31372722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination gene therapy with p53 and Thoc1/p84 is more effective than either single agent in an animal model of human pancreatic adenocarcinoma.
    Yin S; Goodrich DW
    Int J Oncol; 2006 Mar; 28(3):781-5. PubMed ID: 16465385
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The RNA-binding protein RBM47 inhibits non-small cell lung carcinoma metastasis through modulation of AXIN1 mRNA stability and Wnt/β-catentin signaling.
    Shen DJ; Jiang YH; Li JQ; Xu LW; Tao KY
    Surg Oncol; 2020 Sep; 34():31-39. PubMed ID: 32891348
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.
    Tan D; Deeb G; Wang J; Slocum HK; Winston J; Wiseman S; Beck A; Sait S; Anderson T; Nwogu C; Ramnath N; Loewen G
    Diagn Mol Pathol; 2003 Dec; 12(4):201-11. PubMed ID: 14639106
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Circular RNA circ_0074027 indicates a poor prognosis for NSCLC patients and modulates cell proliferation, apoptosis, and invasion via miR-185-3p mediated BRD4/MADD activation.
    Gao P; Wang Z; Hu Z; Jiao X; Yao Y
    J Cell Biochem; 2020 Mar; 121(3):2632-2642. PubMed ID: 31680319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.